OpportunityTitle: Enhanced Surveillance for New Vaccine Preventable Diseases
AdditionalInformationOnEligibility: Applications submitted under this funding opportunity announcement must not include activities that overlap with simultaneously-funded research already awarded to applicants under other awards. Applications that request funds above the ceiling of the award will not move forward to peer review or be eligible for funding.
Description: The NCIRD, Division of Viral Diseases, Epidemiology Branch is projecting to host a 5-year, competitive cooperative agreement starting in FY2016 and having a period of performance lasting September 1, 2016 &#8211; August 31, 2021. This cooperative agreement will fund a network of pediatric medical institutions conducting prospective, active surveillance for acute gastroenteritis (AGE) and acute respiratory illnesses (ARI) in inpatient and emergency department clinical settings, and among healthy controls. Funded activities will provide a principal US pediatric vaccine-preventable (and potentially vaccine preventable) disease surveillance system, to include actively assessing a wide spectrum of AGE, ARI and influenza pathogens, evaluations of vaccine effectiveness for licensed vaccines, burden and natural history of disease for pathogens having upcoming and/or new vaccines, pediatric infectious disease transmission dynamics, vaccination/therapeutic policy and development, vaccine impacts for targeted and vulnerable populations, and socioeconomic and microbiological environments potentially relevant to these public health interventions.
GrantorContactEmailDescription: Grants Policy
GrantorContactText: Deborah Loveys&lt;br/&gt;hft6@cdc.gov&lt;br/&gt;
CloseDateExplanation: Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.